New lens implant shows promise for cataract patients
NCT ID NCT05646004
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested a new lens called 621 in 105 adults having cataract surgery. The lens was implanted during standard surgery to replace the cloudy natural lens. Researchers checked how well patients could see 6 months after surgery and monitored for any safety issues. The goal was to see if the lens is a safe and effective option for restoring clear vision.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- 621 intraocular lens implant
- What this could lead to
- If successful, this lens could provide a safe and effective option for restoring vision after cataract surgery.
- What could go wrong
- This was a small, single-arm study with no comparison group. Long-term benefits and rare risks are not fully known.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SENILE CATARACT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hainan Boao Lecheng Aier Eye Hospital
Qionghai, Hainan, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.